Filtered By:
Source: Drug Safety
Management: ICD-10
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Ranibizumab and Risk of Hospitalisation for Ischaemic Stroke and Myocardial Infarction in Patients with Age-Related Macular Degeneration: A Self-Controlled Case-Series Analysis
Conclusion
This case-series analysis suggests an increased risk of hospitalisation for ischaemic stroke for patients receiving ranibizumab in the 31–60 days risk period. Studies with larger populations are required to confirm the risk in the 1–30 days risk period. No evidence of increased risk of hospitalisation for MI was observed.
Source: Drug Safety - September 27, 2014 Category: Drugs & Pharmacology Source Type: research
